Mirovan 10 mg is a prescription medication containing Mirogabalin Besylate, a novel gabapentinoid designed for the effective management of neuropathic pain. It is particularly beneficial for patients suffering from Diabetic Peripheral Neuropathic Pain (DPNP) and Postherpetic Neuralgia (PHN).
Mirogabalin functions by selectively binding to the α2δ subunit of voltage-dependent calcium channels in the central nervous system. This action reduces calcium influx into nerve terminals, thereby inhibiting the release of excitatory neurotransmitters and diminishing pain signal transmission.